{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:41:13Z","timestamp":1785904873124,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003006","name":"ETH Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003006","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Swiss National Science Foundation"},{"DOI":"10.13039\/501100001808","name":"the Swiss Commission for Technology and Innovation (CTI), Philochem AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001808","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Krebsliga Schweiz\/Krebsforschung Schweiz","award":["KFS-2839-08-2011"],"award-info":[{"award-number":["KFS-2839-08-2011"]}]},{"DOI":"10.13039\/501100004201","name":"Oncosuisse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.cbpa.2015.02.005","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T21:01:58Z","timestamp":1424725318000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Targeting carbonic anhydrase IX with small organic ligands"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-6934","authenticated-orcid":false,"given":"Moreno","family":"Wichert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-4388","authenticated-orcid":false,"given":"Nikolaus","family":"Krall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2015.02.005_bib0250","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0260","first-page":"159","article-title":"The cellular physiology of carbonic anhydrases","volume":"2","author":"Breton","year":"2001","journal-title":"JOP"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0265","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1152\/physrev.2000.80.2.681","article-title":"Carbon dioxide transport and carbonic anhydrase in blood and muscle","volume":"80","author":"Geers","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0270","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/geno.1996.0223","article-title":"Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships","volume":"33","author":"Opavsky","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0275","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0280","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0285","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/mt.2013.17","article-title":"Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity","volume":"21","author":"Lamers","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0290","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0295","first-page":"802","article-title":"Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy","volume":"9","author":"Bui","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","article-title":"Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer","volume":"14","author":"Chiche","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0305","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting proton dynamics and energy metabolism for cancer therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0315","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jcp.22400","article-title":"pH control mechanisms of tumor survival and growth","volume":"226","author":"Parks","year":"2011","journal-title":"J. Cell Physiol"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0325","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.semcancer.2008.03.011","article-title":"Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression","volume":"18","author":"Fang","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0330","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/onc.2010.455","article-title":"New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation","volume":"29","author":"Swietach","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0335","doi-asserted-by":"crossref","first-page":"20299","DOI":"10.1074\/jbc.M109.006478","article-title":"The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths","volume":"284","author":"Swietach","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0340","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0345","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1593\/neo.08178","article-title":"Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles","volume":"10","author":"Giusti","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0350","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1189\/jlb.69.4.522","article-title":"The effects of extracellular pH on immune function","volume":"69","author":"Lardner","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0355","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/ijc.23818","article-title":"Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38","volume":"123","author":"Sauvant","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0360","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.humpath.2007.10.026","article-title":"Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma","volume":"39","author":"Choi","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0365","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lungcan.2006.08.017","article-title":"Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma","volume":"54","author":"Kon-no","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0370","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0375","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0380","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0385","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0390","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0395","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1016\/j.bmc.2013.07.044","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety","volume":"21","author":"Sethi","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0400","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors","volume":"48","author":"Cecchi","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0405","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","article-title":"In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives","volume":"19","author":"Ahlskog","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0410","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates","volume":"57","author":"Moeker","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0415","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/anie.201204631","article-title":"Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries","volume":"52","author":"Krall","year":"2013","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0420","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrclinonc.2014.159","article-title":"The development of immunoconjugates for targeted cancer therapy","volume":"11","author":"Smaglo","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0425","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00259-010-1489-y","article-title":"Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients","volume":"37","author":"van der Veldt","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0430","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11142","article-title":"Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma","volume":"105","author":"Chrastina","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0435","first-page":"495","article-title":"Pretargeting with bispecific anti-renal cell carcinoma\u00d7anti-DTPA(In) antibody in 3 RCC models","volume":"46","author":"van Schaijk","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0440","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2390::AID-CNCR9>3.0.CO;2-F","article-title":"The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts","volume":"80","author":"Kranenborg","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0445","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2012.08.024","article-title":"Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma","volume":"64","author":"Stillebroer","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0450","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1535-7163.MCT-11-0523","article-title":"Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9","volume":"11","author":"Petrul","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0455","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/0008-5472.CAN-06-2531","article-title":"Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent","volume":"67","author":"Dennis","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0460","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","article-title":"Conjugation site modulates the in vivo stability and therapeutic activity of antibody\u2013drug conjugates","volume":"30","author":"Shen","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0465","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bmcl.2011.10.058","article-title":"Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors","volume":"22","author":"Groves","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0470","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0475","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1039\/C4SC00685B","article-title":"A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in mice","volume":"5","author":"Krall","year":"2014","journal-title":"Chem Sci"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0480","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1039\/c1cs15076f","article-title":"Small-molecule discovery from DNA-encoded chemical libraries","volume":"40","author":"Kleiner","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cbpa.2015.02.005_bib0485","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1039\/c1cc15634a","article-title":"20 years of DNA-encoded chemical libraries","volume":"47","author":"Mannocci","year":"2011","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.cbpa.2015.02.005_sbref0490","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nchem.2158","article-title":"Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation","volume":"7","author":"Wichert","year":"2015","journal-title":"Nat Chem"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593115000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593115000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:34:19Z","timestamp":1761273259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593115000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":49,"alternative-id":["S1367593115000228"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2015.02.005","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting carbonic anhydrase IX with small organic ligands","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2015.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}